James Lanthier - Mindset Pharma Chief Officer
| MSSTFDelisted Stock | USD 0.36 0.00 0.00% |
Insider
James Lanthier is Chief Officer of Mindset Pharma
| Age | 48 |
| Phone | 647 938 5266 |
| Web | https://www.mindsetpharma.com |
Mindset Pharma Management Efficiency
The company has return on total asset (ROA) of (0.4794) % which means that it has lost $0.4794 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.433) %, meaning that it generated substantial loss on money invested by shareholders. Mindset Pharma's management efficiency ratios could be used to measure how well Mindset Pharma manages its routine affairs as well as how well it operates its assets and liabilities.Mindset Pharma has accumulated 171.79 K in total debt with debt to equity ratio (D/E) of 0.12, which may suggest the company is not taking enough advantage from borrowing. Mindset Pharma has a current ratio of 1.16, suggesting that it may not be capable to disburse its financial obligations in time and when they become due. Debt can assist Mindset Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Mindset Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mindset Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mindset to invest in growth at high rates of return. When we think about Mindset Pharma's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 8 records | INSIDER Age | ||
| Michael Esq | Fortress Biotech Pref | 57 | |
| Magnus Halle | GH Research PLC | 27 | |
| Samuel Berry | Fortress Biotech Pref | N/A | |
| Florian M | GH Research PLC | 55 | |
| David Jin | Fortress Biotech Pref | 33 | |
| Julie ACA | GH Research PLC | 38 | |
| Theis MD | GH Research PLC | 48 | |
| Thomas Schaible | Fortress Biotech Pref | N/A | |
Management Performance
| Return On Equity | -2.43 | |||
| Return On Asset | -0.48 |
Mindset Pharma Leadership Team
Elected by the shareholders, the Mindset Pharma's board of directors comprises two types of representatives: Mindset Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mindset. The board's role is to monitor Mindset Pharma's management team and ensure that shareholders' interests are well served. Mindset Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mindset Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Arvin CPA, Chief Officer | ||
| Joseph Araujo, Member Officer | ||
| Abdelmalik Slassi, VP Board | ||
| James Lanthier, Chief Officer | ||
| Jason Atkinson, VP Devel | ||
| Chris Irwin, Co Sec |
Mindset Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Mindset Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.43 | |||
| Return On Asset | -0.48 | |||
| Profit Margin | (1.64) % | |||
| Operating Margin | (1.33) % | |||
| Current Valuation | 19.22 M | |||
| Shares Outstanding | 95.25 M | |||
| Shares Owned By Insiders | 9.00 % | |||
| Shares Owned By Institutions | 0.88 % | |||
| Price To Book | 28.87 X | |||
| Price To Sales | 4.83 X |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Mindset OTC Stock
If you are still planning to invest in Mindset Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mindset Pharma's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |